Rein Therapeutics Inc. (RNTX) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 5.45M | 4.33M | 5.17M | 6.6M | 8.33M | 13.66M | 18.68M | 23.16M | 12.76M | 18.27M | 12.79M | 13.95M |
| Cash & Short-Term Investments | 4.45M | 3.21M | 4.05M | 5.72M | 7.43M | 12.87M | 17.65M | 21.92M | 12.04M | 17.31M | 12.07M | 13.67M |
| Cash Only | 4.45M | 3.21M | 4.05M | 5.72M | 7.43M | 12.87M | 17.65M | 21.92M | 12.04M | 17.31M | 12.07M | 13.17M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 499K |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 1.01M | 1.11M | 997K | 692K | 864K | 676K | 780K | 329K | 572K | 746K | 724K | 286K |
| Total Non-Current Assets | 20.84M | 19.83M | 48.53M | 50.88M | 49.3M | 55.58M | 85.53M | 86.24M | 86.43M | 87.74M | 29K | 39K |
| Property, Plant & Equipment | 0 | 0 | 0 | 1K | 1K | 1K | 1K | 2K | 6K | 19K | 29K | 39K |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 6.33M | 6.33M | 6.33M | 6.33M | 6.33M | 0 | 6.33M | 6.33M | 6.33M | 6.33M | 0 | 0 |
| Intangible Assets | 13.5M | 13.5M | 42.2M | 42.2M | 42.2M | 48.53M | 79.2M | 79.2M | 79.2M | 79.2M | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 1M | 2K | 2K | 2.35M | 766K | 2K | 2K | 709K | 892K | 2.19M | 0 | 0 |
| Total Assets | 26.29M | 24.16M | 53.71M | 57.48M | 57.63M | 69.24M | 104.22M | 109.4M | 99.19M | 106.01M | 12.82M | 13.99M |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | -54.38% | -65.11% | -48.47% | -47.46% | -41.9% | -34.68% | 712.8% | 681.93% | - | - | - | - |
| Total Current Liabilities | 13.64M | 6.18M | 5.74M | 7.69M | 5.98M | 5.75M | 5.66M | 4.94M | 4.53M | 4.38M | 1.62M | 1.2M |
| Accounts Payable | 6.26M | 3.98M | 4.12M | 6.03M | 1.15M | 911K | 1.08M | 782K | 2.16M | 1.19M | 484K | 136K |
| Days Payables Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Short-Term Debt | 4.92M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 2.45M | 2.2M | 911K | 183K | 164K | 3.36M | 73K | 255K | 280K | 206K | 10K | 34K |
| Current Ratio | 0.40x | 0.70x | 0.90x | 0.86x | 1.39x | 2.38x | 3.30x | 4.69x | 2.82x | 4.17x | 7.88x | 11.66x |
| Quick Ratio | 0.40x | 0.70x | 0.90x | 0.86x | 1.39x | 2.38x | 3.30x | 4.69x | 2.82x | 4.17x | 7.88x | 11.66x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 1.06M | 1.06M | 1.77M | 46.78M | 46.78M | 9.1M | 48.33M | 48.45M | 49.91M | 94.74M | 0 | 0 |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 1.06M | 1.06M | 1.77M | 1.77M | 1.77M | 8.82M | 3.33M | 3.33M | 3.33M | 3.33M | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 45.01M | 45.01M | 277K | 45.01M | 45.12M | 46.58M | 91.41M | 0 | 0 |
| Total Liabilities | 14.7M | 7.24M | 7.52M | 54.47M | 52.75M | 14.85M | 53.99M | 53.38M | 54.44M | 99.12M | 1.62M | 1.2M |
| Total Debt | 4.92M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 48K | 0 | 0 |
| Net Debt | 478K | -3.21M | -4.05M | -5.72M | -7.43M | -12.87M | -17.65M | -21.92M | -12.04M | -17.27M | -12.07M | -13.17M |
| Debt / Equity | 0.42x | - | - | - | - | - | - | - | - | 0.01x | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 11.59M | 16.92M | 46.19M | 3.01M | 4.87M | 54.39M | 50.23M | 56.02M | 44.75M | 6.89M | 11.2M | 12.79M |
| Equity Growth % | 137.81% | -68.9% | -8.04% | -94.63% | -89.11% | 689.78% | 348.54% | 337.83% | - | - | - | - |
| Book Value per Share | 0.38 | 0.66 | 1.75 | 0.12 | 0.21 | 2.51 | 2.32 | 2.81 | 5.39 | 1.44 | 2.47 | 2.82 |
| Total Shareholders' Equity | 11.59M | 16.92M | 46.19M | 3.01M | 4.87M | 54.39M | 50.23M | 56.02M | 44.75M | 6.89M | 11.2M | 12.79M |
| Common Stock | 114K | 113K | 111K | 131K | 108K | 108K | 108K | 107K | 103K | 91K | 91K | 91K |
| Retained Earnings | -407.11M | -401.27M | -369.3M | -363.72M | -356.9M | -351.4M | -310.42M | -304.57M | -295.63M | -288.52M | -281.18M | -279.35M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -62K | -62K | -44K | -44K | -32K | -18K | -26K | -22K | -63K | -63K | 0 | -2K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |